You are here

  • Home
  • Archive
  • Volume 28, Issue 5
  • Efficacy and Safety of Second-Line 5-Day Dactinomycin in Case of Methotrexate Failure for Gestational Trophoblastic Neoplasia

Article metrics

Article menu
Download PDFPDF
Gestational Trophoblastic Neoplasia
Efficacy and Safety of Second-Line 5-Day Dactinomycin in Case of Methotrexate Failure for Gestational Trophoblastic Neoplasia

 

Online download statistics by month:

Online download statistics by month: February 2019 to April 2024

AbstractFullPdf
Feb 2019400
Mar 20193501
Apr 20192301
May 20194900
Jun 20192400
Jul 20198803
Aug 20196701
Sep 20195700
Oct 20195800
Nov 20196902
Dec 20198000
Jan 20205600
Feb 20206402
Mar 20206702
Apr 20208102
May 20204801
Jun 20203600
Jul 20204502
Aug 20203801
Sep 20202000
Oct 20203300
Nov 20201300
Dec 20202400
Jan 20212300
Feb 20213100
Mar 20215600
Apr 20212700
May 2021600
Jun 2021300
Jul 2021001
Aug 2021200
Sep 2021202
Oct 20215508
Nov 20215300
Dec 20212202
Jan 20225702
Feb 20225400
Mar 20226501
Apr 20223501
May 202213401
Jun 20229400
Jul 20227800
Aug 202211000
Sep 202212001
Oct 20227900
Nov 20229001
Dec 20228600
Jan 20235700
Feb 20239600
Mar 20238401
Apr 20234401
May 20237902
Jun 20232600
Jul 20234401
Aug 20234500
Sep 20232600
Oct 20234002
Nov 20237301
Dec 20237802
Jan 20241200
Feb 20241400
Mar 20247200
Apr 20242301
Total3174049